POST Online Media Lite Edition



 

EU secures 1.8b BioNTech/Pfizer vaccine doses for next 3 years

Christian Fernsby |
The European Commission approved on Saturday a new contract with pharma companies BioNTech/Pfizer to assure vaccines until 2023.

Article continues below



Topics: BIONTECH    PFIZER   

“Happy to announce that the European Commission has just approved a contract for a guaranteed 900 million doses (+900 million options) with BioNTech and Pfizer for 2021-2023," European Commission President Ursula von der Leyen announced on Twitter.

She said that the EU executive body was preparing for the next stage of the fight against the COVID-19 with the new contract.

With the recently secured jabs, the bloc plans to give booster shots to already vaccinated citizens and to inoculate children and teenagers.

Von der Leyen added that BioNTech/Pfizer vaccines were believed to guarantee protection against escape variations of the virus.

This year BioNTech/Pfizer committed to deliver in total 600 million vaccine doses to the bloc.

The EU aims at vaccinating 70% of the adult population by July.


What to read next

Highlights: August 22 - August 27, 2016
Highlights: November 23 - November 28, 2015
Spain, France and Italy to send coronavirus vaccine to small countries